Publication | Open Access

A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer

Breast OncologyMedicinePromising Natural ProductStem Cell ToxicologyCell DeathBreast CancerAnti-cancer AgentIncomplete AutopaghyPharmacologyCell BiologyCancer ResearchTumor Biology